生发中心
独特型
B细胞
自身抗体
系统性红斑狼疮
免疫学
生物
抗体
免疫球蛋白类转换
MHC II级
分子生物学
抗原
疾病
主要组织相容性复合体
医学
单克隆抗体
病理
作者
Kristin Aas-Hanssen,Ane Funderud,Keith M. Thompson,Bjarne Bogen,Ludvig A. Munthe
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2014-08-16
卷期号:193 (6): 2691-2698
被引量:14
标识
DOI:10.4049/jimmunol.1400640
摘要
Abstract Systemic lupus erythematosus (SLE) is marked by a Th cell–dependent B cell hyperresponsiveness, with frequent germinal center reactions and hypergammaglobulinemia. The specificity of Th cells in lupus remains unclear, but B cell Ids have been suggested. A hallmark is the presence of anti-dsDNA, mutated IgG autoantibodies with a preponderance of arginines in CDR3 of the Ig variable H chain (IgVH). B cells can present V region–derived Id peptides on their MHC class II molecules to Id-specific Th cells. We show that Id-specific Th cells support the proliferation of anti-dsDNA Id+ B cells in mice suffering from systemic autoimmune disease with SLE-like features. Mice developed marked clonal expansions of B cells; half of the IgVH sequences were clonally related. Anti-dsDNA B cells made up 40% of B cells in end-stage disease. The B cells expressed mutated IgVH with multiple arginines in CDR3. Hence, Id-driven T cell–B cell collaboration supported the production of classical anti-dsDNA Abs, recapitulating the characteristics of such Abs in SLE. The results support the concept that Id-specific Th cells may trigger the development of SLE and suggest that manipulation of the Id-specific T cell repertoire could play a role in treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI